Abacavir Sulfate (188062-50-2): A Deep Dive

Abacavir form sulfate, identified by the CAS number simply 188062-50-2, is a crucial medication utilized in the management of HIV illness. Its mechanism of function involves inhibiting reverse enzymes, a vital enzyme for viral replication . Patients receiving this pharmaceutical must undergo genetic testing prior to commencement, due to a risk of hypersensitivity response linked to the HLA-B*57:01 allele. This complication can range from mild reaction to a severe, life-threatening emergency. Careful assessment and patient education are therefore essential for safe and successful utilization of abacavir sulfate .

Abarelix: Exploring Compound 183552-38-7

Abarelix, also known as compound 183552-38-7, is a synthetic decapeptide developed for the therapy of enlarged prostate. This drug functions as a specific gonadotropin-releasing hormone (GnRH) inhibitor, effectively reducing male hormone production. Research into the molecule has focused on its ability to reduce associated conditions and potentially offer an alternative to conventional interventions. The molecular profile of 183552-38-7 is sophisticated , showcasing a unique amino acid sequence resulting in its targeted mechanism of effect . More clinical studies are ongoing to thoroughly examine its extended well-being and efficacy .

Abiraterone Acetate: Properties and Identification via CAS 154229-18-2

Abiraterone acetate is a copyrightal antagonist of CYP17A1, an protein crucial for androgen biosynthesis. Its molecular formula is C26H30O3, and it’s frequently identified by its Chemical Abstracts Service (CAS) Registry Number 154229-18-2, providing a identifier for reliable identification. The drug 's properties include significant affinity for CYP17A1, resulting in lower androgen concentrations and exhibiting a white to off-white solid appearance. Further analysis using analytical approaches is typically conducted to confirm identity and consistency.

CAS Number Spotlight: Abacavir Sulfate Salt – 188062-50-2 CAS

This segment highlights on a important pharmaceutical ingredient : Abacavir Sulfate Salt , identified by its unique Chemical Abstracts Service (CAS) registry : 188062-50-2. This medication is a essential element in the treatment of Human Immunodeficiency Virus infection, frequently used in combination other reverse transcriptase inhibitor therapies . Knowing this chemical number is useful for professionals in the pharmaceutical industry .

Key aspects regarding Abacavir Sulfate Form:

  • Function : Serves as a nucleoside reverse transcriptase inhibitor .
  • Application : Mainly used in HIV management.
  • Recognition : The unique identifier 188062-50-2 ensures accurate identification .

Analyzing Abarelix: The Structural Structure (183552-38-7)

Abarelix, identified by the specific code 183552-38-7, represents a fascinating case within the realm of peptide study. Its intricate configuration is crucial to its biological activity. Primarily, this compound is a synthetic hormone antagonist, designed to target and block gonadotropin-releasing releasing hormone. The molecular formula reveals a sequence of residues carefully ordered to facilitate a specific affinity with the GnRH receptor.

  • More investigation are pursued to fully reveal its mode of action.
  • Understanding its creation is vital for expanding generation.
  • The exact order dictates its power.

Abiraterone Salt (154229-18-2): Functions and Molecular Description

{Abiraterone Compound, with the CAS number 154229-18-2, is a pharmaceutical primarily ASIATIC ACID 464-92-6 employed in the management of metastatic gland malignancy , specifically those containing mutations in the protein pathway. It functions as an blocker of cytochrome P450c17, an enzyme responsible for male hormone creation. Chemically, it’s a artificially produced hormone with a complex design , intended to effectively lower androgen levels. Its therapeutic usage has significantly improved outcomes for patients with advanced prostate cancer .

Leave a Reply

Your email address will not be published. Required fields are marked *